CLINICAL RESEARCH: HEART FAILURE
Cardiovascular Features of Heart Failure With Preserved Ejection Fraction Versus Nonfailing Hypertensive Left Ventricular Hypertrophy in the Urban Baltimore Community
The Role of Atrial Remodeling/Dysfunction
Vojtech Melenovsky, MD*, , ,
Barry A. Borlaug, MD*,
Boaz Rosen, MD*,
Ilan Hay, MD*,
Luigi Ferruci, MD, PhD ,
Christopher H. Morell, PhD ,
Edward G. Lakatta, MD ,
Samer S. Najjar, MD and
David A. Kass, MD*,*
* Division of Cardiology, Department of Medicine, Johns Hopkins University, Baltimore, Maryland
Laboratory of Cardiovascular Science
Clinical Research Branch, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland
Department of Mathematical Sciences, Loyola College in Maryland, Baltimore, Maryland
Manuscript received January 18, 2006;
revised manuscript received August 8, 2006,
accepted August 14, 2006.
* Reprint requests and correspondence: Dr. David A. Kass, Ross 835, Division of Medicine, Johns Hopkins Medical Institutions, 720 Rutland Avenue, Baltimore, Maryland 21205. (Email: dkass{at}jhmi.edu).
OBJECTIVES: The purpose of this study was to identify cardiovascular features of patients with heart failure with preserved ejection fraction (HFpEF) that differ from those in individuals with hypertensive left ventricular hypertrophy (HLVH) of similar age, gender, and racial background but without failure.
BACKGROUND: Heart failure with preserved ejection fraction often develops in HLVH patients and involves multiple abnormalities. Clarification of changes most specific to HFpEF may help elucidate underlying pathophysiology.
METHODS: A cross-sectional study comparing HFpEF patients (n = 37), HLVH subjects without HF (n = 40), and normotensive control subjects without LVH (n = 56). All subjects had an EF of >50%, sinus rhythm, and insignificant valvular or active ischemic disease, and groups were matched for age, gender, and ethnicity. Comprehensive echo-Doppler and pressure analysis was performed.
RESULTS: The HFpEF patients were predominantly African-American women with hypertension, LVH, and obesity. They had vascular and systolic-ventricular stiffening and abnormal diastolic function compared with the control subjects. However, most of these parameters either individually or combined were similarly abnormal in the HLVH group and poorly distinguished between these groups. The HFpEF group had quantitatively greater concentric LVH and estimated mean pulmonary artery wedge pressure (20 mm Hg vs. 16 mm Hg) and shorter isovolumic relaxation time than the HLVH group. They also had left atrial dilation/dysfunction unlike in HLVH and greater total epicardial volume. The product of LV mass index and maximal left atrial (LA) volume best identified HFpEF patients (84% sensitivity, 82% specificity).
CONCLUSIONS: In an urban, principally African American, cohort, HFpEF patients share many abnormalities of systolic, diastolic, and vascular function with nonfailing HLVH subjects but display accentuated LVH and LA dilation/failure. These latter factors may help clarify pathophysiology and define an important HFpEF population for clinical trials.
|
Abbreviations and Acronyms
| | Ea
= arterial elastance | | Ees
= end-systolic elastance | | HF = heart failure | | HFpEF = heart failure with preserved ejection fraction | | HLVH = hypertensive left ventricular hypertrophy | | LA = left atrial | | LV = left ventricular | | LVH = left ventricular hypertrophy | | PAWP = pulmonary artery wedge pressure |
|
This article has been cited by other articles:

|
 |

|
 |
 
A. Narayanan, G. P. Aurigemma, M. Chinali, J. C. Hill, T. E. Meyer, and D. A. Tighe
Cardiac Mechanics in Mild Hypertensive Heart Disease: A Speckle-Strain Imaging Study
Circ Cardiovasc Imaging,
September 1, 2009;
2(5):
382 - 390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Borlaug, C. S.P. Lam, V. L. Roger, R. J. Rodeheffer, and M. M. Redfield
Contractility and ventricular systolic stiffening in hypertensive heart disease insights into the pathogenesis of heart failure with preserved ejection fraction.
J. Am. Coll. Cardiol.,
July 28, 2009;
54(5):
410 - 418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Najjar
Heart failure with preserved ejection fraction failure to preserve, failure of reserve, and failure on the compliance curve.
J. Am. Coll. Cardiol.,
July 28, 2009;
54(5):
419 - 421.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S.P. Lam, V. L. Roger, R. J. Rodeheffer, B. A. Borlaug, F. T. Enders, and M. M. Redfield
Pulmonary hypertension in heart failure with preserved ejection fraction a community-based study.
J. Am. Coll. Cardiol.,
March 31, 2009;
53(13):
1119 - 1126.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. T. Maeder and D. M. Kaye
Heart failure with normal left ventricular ejection fraction.
J. Am. Coll. Cardiol.,
March 17, 2009;
53(11):
905 - 918.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Wang and S. F. Nagueh
Current Perspectives on Cardiac Function in Patients With Diastolic Heart Failure
Circulation,
March 3, 2009;
119(8):
1146 - 1157.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. C. Patel, C. R. Ayers, S. A. Murphy, R. Peshock, A. Khera, J. A. de Lemos, J. A. Balko, S. Gupta, P. P.A. Mammen, M. H. Drazner, et al.
Association of Cystatin C With Left Ventricular Structure and Function: The Dallas Heart Study
Circ Heart Fail,
March 1, 2009;
2(2):
98 - 104.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. P. Appleton and S. J. Kovacs
The Role of Left Atrial Function in Diastolic Heart Failure
Circ Cardiovasc Imaging,
January 1, 2009;
2(1):
6 - 9.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kurt, J. Wang, G. Torre-Amione, and S. F. Nagueh
Left Atrial Function in Diastolic Heart Failure
Circ Cardiovasc Imaging,
January 1, 2009;
2(1):
10 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. R. Davis, J. B. Kostis, L. M. Simpson, H. R. Black, W. C. Cushman, P. T. Einhorn, M. A. Farber, C. E. Ford, D. Levy, B. M. Massie, et al.
Heart Failure With Preserved and Reduced Left Ventricular Ejection Fraction in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Circulation,
November 25, 2008;
118(22):
2259 - 2267.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Kushwaha, E. Raichlin, Y. Sheinin, W. K. Kremers, K. Chandrasekaran, G. J. Brunn, and J. L. Platt
Sirolimus affects cardiomyocytes to reduce left ventricular mass in heart transplant recipients
Eur. Heart J.,
November 2, 2008;
29(22):
2742 - 2750.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Chantler, E. G. Lakatta, and S. S. Najjar
Arterial-ventricular coupling: mechanistic insights into cardiovascular performance at rest and during exercise
J Appl Physiol,
October 1, 2008;
105(4):
1342 - 1351.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Zile, T. D. Bennett, M. St. John Sutton, Y. K. Cho, P. B. Adamson, M. F. Aaron, J. M. Aranda Jr, W. T. Abraham, F. W. Smart, L. W. Stevenson, et al.
Transition From Chronic Compensated to Acute Decompensated Heart Failure: Pathophysiological Insights Obtained From Continuous Monitoring of Intracardiac Pressures
Circulation,
September 30, 2008;
118(14):
1433 - 1441.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. T. Emery, I. Jadavji, J. B. Choy, and R. A. Lawrance
Investigating the European Society of Cardiology Diastology Guidelines in a practical scenario
Eur J Echocardiogr,
September 1, 2008;
9(5):
685 - 691.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Handoko and W. J. Paulus
Polishing the diastolic dysfunction measurement stick
Eur J Echocardiogr,
September 1, 2008;
9(5):
575 - 577.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. D. Chantler, V. Melenovsky, S. P. Schulman, G. Gerstenblith, L. C. Becker, L. Ferrucci, J. L. Fleg, E. G. Lakatta, and S. S. Najjar
The sex-specific impact of systolic hypertension and systolic blood pressure on arterial-ventricular coupling at rest and during exercise
Am J Physiol Heart Circ Physiol,
July 1, 2008;
295(1):
H145 - H153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Moens, E. Takimoto, C. G. Tocchetti, K. Chakir, D. Bedja, G. Cormaci, E. A. Ketner, M. Majmudar, K. Gabrielson, M. K. Halushka, et al.
Reversal of Cardiac Hypertrophy and Fibrosis From Pressure Overload by Tetrahydrobiopterin: Efficacy of Recoupling Nitric Oxide Synthase as a Therapeutic Strategy
Circulation,
May 20, 2008;
117(20):
2626 - 2636.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H Manisty and D. P Francis
Ejection fraction: a measure of desperation?
Heart,
April 1, 2008;
94(4):
400 - 401.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. P. Brunner-La Rocca
Do we understand why the heart fails?
Eur. Heart J.,
March 2, 2008;
29(6):
698 - 700.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Osranek, J. H. Eisenach, B. K. Khandheria, K. Chandrasekaran, J. B. Seward, and M. Belohlavek
Arterioventricular Coupling and Ventricular Efficiency After Antihypertensive Therapy: A Noninvasive Prospective Study
Hypertension,
February 1, 2008;
51(2):
275 - 281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. N. DeMaria, J. J. Bax, O. Ben-Yehuda, P. Clopton, G. K. Feld, G. S. Ginsburg, B. H. Greenberg, J. D. Knoke, W. Y.W. Lew, J. A.C. Lima, et al.
Highlights of the year in JACC 2007.
J. Am. Coll. Cardiol.,
January 29, 2008;
51(4):
490 - 512.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Kass
An epidemic of dyssynchrony: but what does it mean?
J. Am. Coll. Cardiol.,
January 1, 2008;
51(1):
12 - 17.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. van Heerebeek, N. Hamdani, M. L. Handoko, I. Falcao-Pires, R. J. Musters, K. Kupreishvili, A. J.J. Ijsselmuiden, C. G. Schalkwijk, J. G.F. Bronzwaer, M. Diamant, et al.
Diastolic Stiffness of the Failing Diabetic Heart: Importance of Fibrosis, Advanced Glycation End Products, and Myocyte Resting Tension
Circulation,
January 1, 2008;
117(1):
43 - 51.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W.H. W. Tang and G. S. Francis
The Year in Heart Failure
J. Am. Coll. Cardiol.,
December 11, 2007;
50(24):
2344 - 2351.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Kass, H. C. Champion, and J. A. Beavo
Phosphodiesterase Type 5: Expanding Roles in Cardiovascular Regulation
Circ. Res.,
November 26, 2007;
101(11):
1084 - 1095.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. A. Borlaug, V. Melenovsky, M. M. Redfield, K. Kessler, H.-J. Chang, T. P. Abraham, and D. A. Kass
Impact of Arterial Load and Loading Sequence on Left Ventricular Tissue Velocities in Humans
J. Am. Coll. Cardiol.,
October 16, 2007;
50(16):
1570 - 1577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S.P. Lam, V. L. Roger, R. J. Rodeheffer, F. Bursi, B. A. Borlaug, S. R. Ommen, D. A. Kass, and M. M. Redfield
Cardiac Structure and Ventricular-Vascular Function in Persons With Heart Failure and Preserved Ejection Fraction From Olmsted County, Minnesota
Circulation,
April 17, 2007;
115(15):
1982 - 1990.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. R. Zile and M. M. LeWinter
Left Ventricular End-Diastolic Volume Is Normal in Patients With Heart Failure and a Normal Ejection Fraction: A Renewed Consensus in Diastolic Heart Failure
J. Am. Coll. Cardiol.,
March 6, 2007;
49(9):
982 - 985.
[Full Text]
[PDF]
|
 |
|
|